The present invention addresses the problem of discovering a novel peptide useful as an active ingredient of a drug for the treatment or prevention of cancer and providing the use of the polypeptide as an immunity inducer. An immunity inducer containing as an active ingredient (a) a polypeptide comprising amino acids shown by SEQ ID NOS: 3-45 or (b) a polypeptide in which one to several amino acids of the polypeptide of (a) are deleted substituted or added is useful as a drug for the treatment or prevention of cancer.
